bioactive ring systems (MultiTarget Pharmaceuticals)
Structured Review

Bioactive Ring Systems, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multitarget/bioactive+ring+systems/pmc11443490-94-4-26
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Chemoinformatic Characterization of NAPROC-13: A Database for Natural Product 13 C NMR Dereplication"
Article Title: Chemoinformatic Characterization of NAPROC-13: A Database for Natural Product 13 C NMR Dereplication
Journal: Journal of Natural Products
doi: 10.1021/acs.jnatprod.4c00530
Figure Legend Snippet: Most frequent potentially bioactive ring systems in NAPROC-13 (“Magic Rings”).
Techniques Used:
Related Articles
other:Article Title: Chemoinformatic Characterization of NAPROC-13: A Database for Natural Product 13 C NMR Dereplication Article Snippet: The main classes of |
![Screening potential candidates of TET-family inhibitors in infected hiPSC-CMs via computational molecular docking simulation. (A) The flowchart of the drug screening platform for molecular docking analysis of TET2 in complex with its DNA substrate and representative inhibitors. (B) Schematic representation of the molecular docking of representative TET2 <t>inhibitors—Bobcat339,</t> TFMB-2HG, and TETi76—into the catalytic pocket of TET2. The figure illustrates the catalytic core of TET2 binding to methylated DNA, followed by computational screening and docking of small-molecule inhibitors into the active site. (C) TET2 in complex with DNA substrate (Protein Data Bank [PDB] ID: 7NE3). Left: Overall structure showing TET2 (ribbon representation) bound to DNA (sticks in orange and magenta). Middle: Close-up view of the catalytic pocket highlighting the interaction surface. Right: 2-dimensional (2D) interaction diagram illustrating contacts between TET2 and the DNA substrate. (D) TET2 in complex with TETi76. Left: Chemical structure of TETi76. Middle: Docked pose of TETi76 in the TET2 catalytic site. Right: 2D interaction diagram showing hydrogen bonding and hydrophobic contacts. (E) TET2 in complex with Bobcat339. Left: Chemical structure of Bobcat339. Middle: Docked binding mode of Bobcat339 in the catalytic site. Right: 2D interaction map illustrating hydrogen bonds, hydrophobic interactions, and halogen bonding. (F) TET2 in complex with TFMB-2HG. Left: Chemical structure of TFMB-2HG. Middle: Docked pose within the TET2 active site. Right: 2D interaction map showing hydrogen bonding and minimal hydrophobic interactions.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_0876/pmc12280876/pmc12280876__bmr.0229.fig.005.jpg)
